08:00 , Jan 6, 2014 |  BioCentury  |  Finance

4Q Stock Wrap-Up: All's well that ends well

Although two segments lost ground in 4Q13, all of biotech's market cap groups finished 2013 in the black. Large caps valued at more than $5 billion led the way in the fourth quarter, tacking on...
08:00 , Nov 11, 2013 |  BC Week In Review  |  Company News

Thermogenesis hematology news

ThermoGenesis said it is eliminating 11 positions as part of a restructuring expected to save $1.5 million per year. The company said it will focus on speeding up adoption of its AXP AutoXpress Platform in...
07:00 , Oct 15, 2007 |  BC Week In Review  |  Clinical News

AXP AutoXpress Platform regulatory update

FDA granted 510(k) clearance for KOOL's AXP AutoXpress Platform to isolate and capture stem cells from umbilical cord blood. GE Healthcare, a unit of General Electric Co. (GE, Fairfield, Conn.), has exclusive global distribution rights...